Legal Opinion
Biovail Corp. v. U.S. Food & Drug Administration
District Court, District of Columbia
Decided March 22, 2007No. Civil Action 06-1487 (RMU)PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
RICARDO M. URBINA, District Judge.
Denying the Plaintiffs’ Motion for Injunctive Relief 1
I. INTRODUCTION
The plaintiffs, Biovail Corporation and Biovail Laboratories International SRL (collectively, “the plaintiff’ or “Biovail”) manufacture the drug Wellbutrin XL. On August 23, 2006, the plaintiff brought suit and filed a motion for a temporary restraining order (“TRO”) against the defendants Food and Drug Administration and Andrew C. Von Eschenbach 2 (collectively “the defendant” or “FDA”) challenging the FDA’s consideration of generic versions of Wellbutrin XL for approval.…
2Cases cited32 opinions
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Califano v. SandersSupreme Court of the United States · 1977
- Bowman Transportation, Inc. v. Arkansas-Best Freight System, Inc.Supreme Court of the United States · 1975
- Mazurek v. ArmstrongSupreme Court of the United States · 1997
27 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Viropharma Incorporated v. HamburgDistrict Court, District of Columbia · 2012
- Astellas Pharma US, Inc. v. Food & Drug AdministrationDistrict Court, District of Columbia · 2009
- Mylan Pharmaceuticals, Inc. v. SebeliusDistrict Court, District of Columbia · 2012
- Astellas Pharma US, Inc. v. Food and Drug AdministrationDistrict Court, District of Columbia · 2009
- Whaleco Inc. v. Shein Technology LLCDistrict Court, District of Columbia · 2025